Arkadios Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,131
Closed -$135K 1673
2021
Q3
$135K Hold
1,131
0.02% 607
2021
Q2
$110K Hold
1,131
0.01% 697
2021
Q1
$99K Hold
1,131
0.02% 539
2020
Q4
$108K Buy
+1,131
New +$117K 0.02% 426

Other funds holding TNDM

Arkadios Wealth Advisors's TNDM Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 1,131 shares — an estimated $135K sold.

Arkadios Wealth Advisors first reported a position in TNDM in Q4 2020 and held it in 4 quarters. The position peaked at $135K in Q3 2021. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 1,131 Tandem Diabetes Care shares in Q4 2021, an estimated $135K.
  • Arkadios Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 4 quarters.
  • Arkadios Wealth Advisors's Tandem Diabetes Care position peaked at $135K in Q3 2021.
  • 388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.